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ABSTRACT
Objective: The use of sedation in upper 
gastrointestinal endoscopy is widespread 
because of better patient tolerance. As this 
sedation is usually performed by non­
anesthesiologists in and outside of hospital 
settings, possible adverse effects arising during 
the procedure must be dealt with carefully. In this 
study, the safety and efficacy of midazolam for 
conscious sedation in 100 patients undergoing 
upper gastrointestinal endoscopy were evaluated 
prospectively.
Patients and Methods: Hundred consecutive 
patients undergoing upper gastrointestinal 
endoscopy were sedated with intravenous 
midazolam. The dose of midazolam was titrated 
according to the patient’s need and the duration 
of the procedure. Heart rate and oxygen 
saturation of all the patients were continuously 
monitored during the procedure and any 
complications were recorded. The amnesic effect 
of midazolam and patient comfort were also 
evaluated.
Results: During the procedure, absence of 
oxygen desaturation (Sa02 > 95%) was found in 
80%, mild oxygen desaturation (95% > Sa02 > 
92%, at least 15 seconds duration) in 16%, and
severe oxygen desaturation (Sa02 < 92%, at 
least 15 seconds duration) in 4%. Twenty-six 
patients had tachycardia only during the insertion 
of the endoscope, 17 patients had it throughout 
the procedure. Ventricular premature beats were 
recorded in two patients. Different degrees of 
amnesia were seen in 60% of the patients and 
the comfort level was excellent in 41%, good in 
43%, and fair in 16%.
Conclusion: Sedation of patients undergoing 
upper gastrointestinal endoscopy with 
intravenous midazolam results in better tolerance 
of the procedure. Routine monitoring must be 
provided because of the risks of desaturation and 
arrhythmia.
K e y  W o r d s :  Midazolam, Conscious sedation, 
Upper gastrointestinal endoscopy.
IN T R O D U C T IO N
Despite the fact that the vast majority of 
diagnostic endoscopic procedures can be 
performed under topical throat anesthesia alone, 
it has been shown that the use of sedation results 
in better patient tolerance and less hemodynamic 
stress in response to insertion and manipulation 
of the endoscope (1). Midazolam is the most
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widely used agent for this purpose, due to its 
short acting time and amnesic property (1). The 
aim of this study was to evaluate the effects of 
sedation in 100 patients undergoing upper 
gastrointestinal endoscopy at the Marmara 
University Institute of Gastroenterology between 
November 2000 and March 2001.
M A TER IA LS A N D  M E T H O D S
After giving information about the procedure, the 
age, gender, body weight, and prior experiences 
(a history of previous upper gastrointestinal 
endoscopy) of 100 consecutive patients 
undergoing upper gastrointestinal endoscopy 
were recorded. Associated medical illnesses 
were graded according to the American Society 
of Anesthesiologists’ Physical Status 
Classification (ASA grade) (ASA I: A healthy 
patient without any systemic medical problems 
other than surgical; ASA II: A patient with mild 
systemic disease that results in no functional 
limitation; ASA III; A patient with severe systemic 
disease that results in functional impairment; 
ASA IV: A patient with a severe systemic disease 
that is a constant threat to life; ASA V: A 
moribund condition in a patient who is not 
expected to survive with or without operation; 
ASA VI: Declared brain death whose organs are 
being harvested for transplantation; E: 
Emergency operation is required) (2). Oxygen 
saturation and heart rate were continuously 
monitored from 10 min. before sedation until the 
end of the endoscopy. Topical pharyngeal 
anesthesia was administered with lidocaine 10% 
(Xylocain®, Eczaciba§i). A 22-gauge cannula 
was placed intravenously for application of the 
sedation drugs. Level of sedation was assessed 
using the following sedation scale: 1: Awake, 
alert, agitated; 2: Slightly drowsy, easily aroused; 
3: Frequently drowsy, arousable, drifts off to 
sleep during conversation; 4: Somnolent, 
minimal or no response to physical stimulation. A 
bolus dose of 0.04 mg/kg midazolam 
(Dormicum®, Roche) was given intravenously 2 
min. before the esophageal intubation by the 
same anesthesiologist. For patients aged over 60 
years 1 mg. midazolam was used. Sedation level 
was assessed between 2 and 3 by giving 50% of 
the initial dose as required. The procedures were 
performed by three different endoscopists. The 
duration of the procedure and complications such
as a fall in oxygen saturation and arrhythmia 
were recorded. Oxygen desaturation was 
assessed as absence of oxygen desaturation 
(Sa02 > 95%), mild oxygen desaturation (95% > 
Sa02 > 92%, at least 15 seconds duration), and 
severe oxygen desaturation (Sa02 < 92%, at 
least 15 seconds duration). Before discharge, 
procedural amnesia was reported by the patient 
according to a four-point scale (1: Do not 
remember the procedure, 2: Remember only the 
esophageal intubation, 3: Remember only the 
withdrawal of endoscope, 4: No amnesia) and 
the patient’s comfort level was assessed 
according to a “comfort score” (1: Excellent, 2: 
Good, 3: Fair, 4: Poor).
All values were expressed as mean ± standard 
deviation. Spearman’s rank test was used to 
analyze the correlations of oxygen desaturation 
with age, body weight or duration of procedure 
and chi-square test for gender. A P value less 
than 0.05 was considered statistically significant.
RESULTS
A total of 100 patients received midazolam (58 
women and 42 men). The demographic 
characterization and a prior experience of the 
patient, duration of the procedure, and the dose 
of midazolam used are shown in Table I. The 
baseline Sa02 was 98.3 ± 1.0 %. During the 
procedure, there was no desaturation in 80%, 
mild oxygen desaturation in 16%, and severe 
oxygen desaturation in 4% (Fig 1). 
Supplementary oxygen at 5 L/min via nasal 
cannula was given to patients in the severe 
oxygen desaturation group. Age (correlation 
coefficients.19, p =0.058), gender (p=0.06), 
body weight (correlation coefficients. 19, p 
=0.054), or total endoscopy time (correlation 
coefficients.16, p =0.11) was not related to the 
degree of oxygen desaturation. In ASA III 
patients, severe desaturation was found in 14.3% 
while it was 3.2% in ASA l-ll patients (Fig 2). 
Twenty-six patients had tachycardia only during 
the insertion of the endoscope, 17 patients had it 
throughout the procedure. Ventricular premature 
beats were recorded in two patients but there 
was no need to use an anti-arrhythmic agent (Fig
3). There were no deaths, episodes of cardio­
respiratory arrest, or pulmonary aspirations 
amoung our patients.
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T a b le  I.: D em ograph ic  ch a ra c te riz a tio n  an d  prior e x p e r ie n c e  
of p a tien t, d u ra tio n  of p ro c e d u re  a n d  d o s e  of 
m idazo lam  u sa g e .
Female Male
(n=58) (n=42)
Age (year) 
(mean±SD)
49 ± 14 45 ± 15
Body weight (kg) 
(mean ± SD)
64 ± 12 76 ±12
ASA grade 
(number of patients) 
I 33 27
II 23 10
III 2 5
Prior experience 
(number of patients) 18 16
Duration of procedure 
(minute) (mean ± SD)
9.4 ±4.2 11.3 ±6.3
Midazolam dose (mg) 
(mean ± SD)
3.8 ±1.2 3.9 ±1.1
ASA grade: American Society of Anesthesiologists Physical Status Classification.
Oxygen desaturation
|  Mild desaturation 
|  Severe desaturation
Gender
F l g . l  : Oxygen desaturation  of patients.
ASA I & II ASA III
ASA Classification
ASA: American Society of Anesthesiologists Physical Status Classification
F ig  . 2 :  Oxygen desatu ration  of patients according to the ASA 
Classification.
s
c<0
a
■B
È
E
Arrhythmia
Normal sinus 
rhythm
Tachycardia during 
intubation
Tachycardia during 
procedure
I B  Ventricular
premature beats
Gender
F ig .3 :  Arrhythm ia in patients.
Thirty percent of patients did not rem em ber the 
p rocedure , 26%  rem em bered  on ly  the 
esophageal intubation, 4%  rem em bered only the 
w ithdrawal ot the endoscope, and 40%  did not 
have any am nesia . The com fo rt leve l was 
excellent in 41%, good in 43% , and fa ir in 16%.
DISCUSSION
Conscious sedation is the use of m edication to 
m inim ally depress the level of consciousness in a 
patient while allow ing the patient to continually 
and independently m aintain a patent a irway and 
respond app ro p ria te ly  to ve rba l com m ands 
and/or gentle stim ulation (3). The task force of 
the A m erican  S oc ie ty  of A n e s thes io log is ts  
decided that the term  “sedation and ana lgesia” 
more accurately defines this therapeutic goal 
than does the com m only used term  “conscious 
sedation” (4). This type of sedation can be used 
in procedures such as all types of endoscopy, 
lum bar puncture, card iovers ion , w ound care, 
burn debridem ent, bone m arrow  aspiration and 
p lacem ent or removal of im planted devices and 
tubes. It can also be used in procedures during 
which the patient suffers anxiety but m ust remain 
as m otionless as possible, such as m agnetic 
resonance im aging and com puted tom ography 
scan. Another type of sedation, deep sedation or 
M on ito red  A nes thes ia  C are  (M AC ), uses 
m ed ica tion  to induce a con tro lled  s ta te  of 
depressed consciousness or unconsciousness in 
which the patient may experience partia l or 
com plete loss of protective reflexes including the
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ab ility  to indepe nden tly  and con tinuous ly  
m aintain a patent a irw ay (3). However, only 
anesthesio log ists m ust adm in ister this type of 
sedation. On the other hand, the patient may 
progress from  one degree of sedation to another 
depending on his underlying medical status, the 
m edications adm inistered, dosage and route of 
adm inistration. Excessive sedation may result in 
cardiac or respiratory depression that must be 
rapidly recognized and appropria te ly managed to 
avoid the risk of hypoxic brain damage, cardiac 
arrest, or death. So, observation and monitoring 
of the patient by a person skilled in advanced life 
support is very im portant in this type of procedure
(5). In this study, an anesthesio log ist maintained 
the sam e level of sedation. This is the main 
reason for the low com plication rate. However, 
seda tion  during  upper gas tro in tes tina l 
endoscopy is usua lly  perfo rm ed by non ­
anesthes io log is ts  in and outs ide of hospita l 
settings. Because of safety reasons, there are 
studies offering only topical th roat anesthesia. 
Tan and Freem an (6 ) studied 244 cases and 
found that only 32%  of patients who had throat 
spray to lerated the endoscopy well, com pared to 
70%  of those who chose sedation. They claimed 
that male patients, those with lower anxiety 
levels, and those over 50 years old, tolerated 
endoscopy w ith throat spray better. Cam po et al 
(7) studied 509 patients undergoing diagnostic 
gastroscopy after the adm inistration of topical 
pharyngeal anesthesia, w ithout sedation. Patient 
to lerance was poor in 84 of 273 (31%) patients 
undergoing gastroscopy for the first time, and in 
61 of 236 (26%) patients with prior experience. In 
our study, there was no poor patient tolerance 
even in the “no am nesia” group.
H ypoxia  is one of the  m ost im portan t 
com p lica tions  of upper gas tro in tes tina l 
endoscopy (1). In this study, we found absence 
of oxygen desaturation in 80%, mild oxygen 
desa tu ra tion  in 16%, and severe  oxygen 
desaturation in 4%. W ang et al (8 ) studied 
oxygen saturation using pulse oxim etry in 1 0 0  
sedated and 1 0 0  non-sedated patients breathing 
room air during d iagnostic upper gastrointestinal 
endoscopy. Hypoxia (S a 0 2  < 92%, at least 15 
seconds duration) occurred in 17% and 6 % of 
sedated  pa tien ts  and non-seda ted  pa tients, 
respectively (p<0.03). Mild desaturation (S a 0 2  < 
94%, less than 15 seconds duration) occurred in 
47%  of sedated patients com pared with 12% of
non-sedated pa tien ts (p<0.001). Sedation 
s ign ifican tly  increases the inc idence of 
desaturation and hypoxia but they can occur 
w ithout sedation also. Iwao et al (9) studied 120 
pa tien ts  undergo ing non-seda ted  d iagnostic  
upper gastrointestinal endoscopy and observed 
no oxygen desaturation (Sa02 > 95%) 56%, mild 
oxygen desaturation (95% > S a 0 2  > 90%) 35%, 
and severe oxygen desaturation (S a 0 2  < 90%) 
9%. They claimed that age, gender, smoking, 
hemoglobin level, body mass index, or total 
endoscopy time were not related to the degree of 
oxygen desa tu ra tion  and recom m ended 
continuous monitoring of arterial oxygenation in 
all patients during the procedure. Basal S a 0 2  < 
95%, respiratory disease, more than one attempt 
needed for intubation, emergency procedure and 
ASA score of III or IV are found as predictive 
factors of oxygen desaturation during upper 
gas tro in tes tina l endoscopy in non-sedated 
patients (10,11). Such patients require very close 
m on ito ring  and endoscop is ts  should be 
especially alert to the possibility of respiratory 
depress ion  in these cases. The e ffect of 
supplem entary nasal oxygen is also studied in 
sedated  pa tien ts  and it is found that 
supplem entary oxygen abolishes desaturation 
and hypoxia (8 ). The routine use of supplemental 
oxygen would greatly reduce this unnecessary 
risk to patients.
Upper gas tro in tes tina l endoscopy is often 
accom panied by tachycardia because of the 
stress response (12). This can be dangerous for 
patients with coronary heart disease (CHD). 
E lectrocard iograph record ing using a Holter 
monitor was performed in 71 patients with stable 
CHD, to check for silent ischem ia, and during 
gastroscopy, 30 pa tien ts  (42% ) had s ilen t 
ischem ia, but on ly 1 pa tien t ( 1 %) becam e 
sym ptom atic (13). W ilcox et al (14) studied 25 
hosp ita lized  patients w ith  w e ll-de fined  CHD 
during endoscop ic  p rocedures requiring 
intravenous sedation. Twenty four percent of 
pa tien ts  had one or m ore ep isodes of 
e lec troca rd iog raph ic  ischem ia  during the 
recording periods. Sedation may provide some 
p ro tection  aga inst hem odynam ic stress in 
response to insertion and manipulation of the 
endoscope (15). But tachycardia was seen in 
43%  of the patients in our study, although they 
had an acceptable level of sedation.
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In conclusion, sedation applied by a skilled 
person during upper gastro in testina l endoscopy 
provides better patient to lerance with a lower 
com plica tion  rate. As the re  are risks of 
desatura tion  and a rrhy thm ia  during th is 
procedure, even w ithout sedation, adverse risk 
factors should be carefu lly identified and routine 
monitoring, at least w ith a pulse oximeter, should 
be carried out.
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